Cefaclor is NOT recommended for pneumonia in a 3-year-old
Do not use cefaclor for community-acquired pneumonia in children. The authoritative 2011 PIDS/IDSA pediatric pneumonia guidelines do not include cefaclor in their treatment recommendations for any age group or clinical scenario 1, 2.
Recommended Treatment Instead
For Outpatient Treatment (Mild CAP):
- First-line: Amoxicillin 90 mg/kg/day divided into 2 doses (maximum 4 g/day) 2
- Alternative: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 2
For Inpatient Treatment (Severe CAP):
- Ampicillin 150-200 mg/kg/day IV every 6 hours 1
- Penicillin G 200,000-250,000 units/kg/day IV every 4-6 hours 1
- Alternatives: Ceftriaxone 50-100 mg/kg/day IV every 12-24 hours or cefotaxime 150 mg/kg/day IV every 8 hours 1
Why Cefaclor is Inappropriate
The PIDS/IDSA guidelines specifically recommend second- or third-generation cephalosporins as alternatives for oral therapy, listing cefpodoxime, cefuroxime, and cefprozil 1, 2. Cefaclor, a second-generation cephalosporin, is notably absent from these recommendations despite other second-generation agents being included.
Key considerations:
- Cefaclor has inferior activity against Streptococcus pneumoniae (the most common bacterial cause of pediatric CAP) compared to amoxicillin
- The guidelines emphasize high-dose amoxicillin (90 mg/kg/day) as the preferred oral agent for pneumococcal coverage 2
- Even for β-lactamase producing organisms, amoxicillin-clavulanate is preferred over cefaclor 2
If Cefaclor Were to Be Used (Not Recommended)
The FDA label indicates dosing of 20-40 mg/kg/day divided every 8 hours for pediatric infections 3. For pneumonia specifically, the label states "doses may be doubled" for more severe infections, suggesting 40 mg/kg/day 3. However, this is a moot point as cefaclor should not be selected for pneumonia treatment in the first place.
Common Pitfall
Do not confuse cefaclor with the recommended second-generation cephalosporins (cefuroxime, cefprozil, cefpodoxime). While these are chemically similar, only specific agents have been validated and recommended by guidelines for pediatric pneumonia treatment.